These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 2451185

  • 21. Alpha-interferon and isoprinosine in adult-onset subacute sclerosing panencephalitis.
    Gokcil Z, Odabasi Z, Demirkaya S, Eroglu E, Vural O.
    J Neurol Sci; 1999 Jan 01; 162(1):62-4. PubMed ID: 10064170
    [Abstract] [Full Text] [Related]

  • 22. [Treatment of subacute sclerosing panencephalitis with methisoprinol. Considerations a propos of 3 cases].
    Defanti CA, Mirabile D.
    Riv Neurobiol; 1981 Jan 01; 27(34):621-5. PubMed ID: 6189177
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Subacute sclerosing panencephalitis: influence of the clinical course and treatment with isoprinosine on non-specific cell-mediated and humoral immunity.
    Vainiene M, Członkowska A, Korlak J.
    Acta Neurol Scand; 1983 May 01; 67(5):275-84. PubMed ID: 6192674
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Inosiplex for SSPE.
    Chalmers TC, Smith H.
    Lancet; 1982 Jun 26; 1(8287):1475. PubMed ID: 6177984
    [No Abstract] [Full Text] [Related]

  • 27. Inosiplex therapy in subacute sclerosing panencephalitis. A multicentre, non-randomised study in 98 patients.
    Jones CE, Dyken PR, Huttenlocher PR, Jabbour JT, Maxwell KW.
    Lancet; 1982 May 08; 1(8280):1034-7. PubMed ID: 6176821
    [Abstract] [Full Text] [Related]

  • 28. Clinical effects of MND-19 (Inosiplex) on subacute sclerosing panencephalitis--a multi-institutional collaborative study--The Inosiplex-SSPE Research Committee.
    Fukuyama Y, Nihei K, Matsumoto S, Ebina T, Kamoshita S, Sato T, Arima M, Yabuuchi H, Ueda S, Ohtahara S.
    Brain Dev; 1987 May 08; 9(3):270-82. PubMed ID: 2444125
    [Abstract] [Full Text] [Related]

  • 29. [Changes of cognitive and emotional processes during immunostimulatory treatment in subacute sclerosing panencephalitis].
    Jakubowska T, Luczywek E, Sobczyk W, Piłkowska E.
    Neurol Neurochir Pol; 1993 May 08; 27(1):45-53. PubMed ID: 7684827
    [Abstract] [Full Text] [Related]

  • 30. SSPE incidence, therapy receive renewed attention.
    Gunby P.
    JAMA; 1981 Aug 28; 246(9):927, 931-2. PubMed ID: 6166765
    [No Abstract] [Full Text] [Related]

  • 31. Trihexyphenidyl and isoprinosine in the treatment of subacute sclerosing panencephalitis.
    Nunes ML, da Costa JC, da Silva LF.
    Pediatr Neurol; 1995 Sep 28; 13(2):153-6. PubMed ID: 8534281
    [Abstract] [Full Text] [Related]

  • 32. Isoprimosine in subacute sclerosing panencephalitis.
    Alter M.
    Neurology; 1980 Feb 28; 30(2):221-2. PubMed ID: 6153462
    [No Abstract] [Full Text] [Related]

  • 33. [Assessment of early treatment results with antineoplaston AS2-1 in subacute sclerosing panencephalitis].
    Sobczyk W, Piłkowska E, Iwińska-Buksowicz B, Jakubowska T.
    Neurol Neurochir Pol; 1997 Feb 28; 31(6):1147-56. PubMed ID: 9591301
    [Abstract] [Full Text] [Related]

  • 34. [The evaluation of the use of antineoplaston AS2-1 treatment in subacute sclerosing panencephalitis].
    Sobczyk W, Piłkowska E, Iwińska-Buksowicz B.
    Neurol Neurochir Pol; 1999 Feb 28; 33(4):797-805. PubMed ID: 10612094
    [Abstract] [Full Text] [Related]

  • 35. Treatment of subacute sclerosing panencephalitis: an overview.
    Taylor WJ, DuRant RH, Dyken PR.
    Drug Intell Clin Pharm; 1984 May 28; 18(5):375-81. PubMed ID: 6202474
    [Abstract] [Full Text] [Related]

  • 36. Progressive CT abnormalities despite clinical improvement in SSPE treated with inosiplex.
    Noetzel MJ, Dodson WE.
    Ann Neurol; 1983 Apr 28; 13(4):457-60. PubMed ID: 6188412
    [Abstract] [Full Text] [Related]

  • 37. Lymphocyte subsets, TNF alpha and interleukin-4 levels in treated and untreated subacute sclerosing panencephalitis patients.
    Anlar B, Guven A, Köse G, Okur H, Kose O, Aydin OF, Kabakus N, Altunbasak S, Herguner O, Sonmez M, Serdaroglu A.
    J Neuroimmunol; 2005 Jun 28; 163(1-2):195-8. PubMed ID: 15885323
    [Abstract] [Full Text] [Related]

  • 38. [Subacute sclerosing panencephalitis: serial CT studies and magnetic resonance imaging].
    Inada H, Hattori H, Nakajima S, Iwamura C, Tanaka A, Kim M, Matsuoka O, Murata R, Inoue Y.
    No To Hattatsu; 1986 May 28; 18(3):199-206. PubMed ID: 2423102
    [No Abstract] [Full Text] [Related]

  • 39. SSPE, measles virus, and the matrix protein: report of a case with unusual immunochemical findings.
    Mandelbaum DE, Hall WW, Paneth N, Wolff RR, DeVivo DC.
    Ann Neurol; 1981 Oct 28; 10(4):351-4. PubMed ID: 6172078
    [Abstract] [Full Text] [Related]

  • 40. [Comparison of the results of the treatment of patients with SSPE using various immunomodulating preparations].
    Sobczyk W, Kulczycki J, Piłkowska E, Iwińska B, Milewska D, Szmigielski S.
    Neurol Neurochir Pol; 1991 Oct 28; 25(5):626-33. PubMed ID: 1725554
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.